$KVA, KVB K-V Pharmaceutical Co Insider Trading
Get free email notifications about insider trading in K-V Pharmaceutical Co.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in K-V Pharmaceutical Co. Insider overview, share value development, latest insider transactions and email notifications about new events in K-V Pharmaceutical Co for free.
CIK Number: 0000057055
IRS Number: 430618919
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: KVA, KVB
Company Address: 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD 63005
Phone number: 3146456600
Former name: KV PHARMACEUTICAL CO /DE/, date of change: 1992-07-03
Former name: The below name is not an actual previous name of the Issuer.
K-V Pharmaceutical Co Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 20 2013 | KVA, KVB | K-V Pharmaceutical ... | Silver Point Capital L.P. | 10% Owner | Buy | P | 46.50 | 25,000 | 1,162,500 | 2,023,883 | 2 M to 2 M (+1.25 %) |
Nov 15 2013 | KVA, KVB | K-V Pharmaceutical ... | Silver Point Capital L.P. | 10% Owner | Buy | P | 44.50 | 50,000 | 2,225,000 | 1,998,883 | 1.9 M to 2 M (+2.57 %) |
Nov 15 2013 | KVA, KVB | K-V Pharmaceutical ... | Silver Point Capital L.P. | 10% Owner | Buy | P | 42.75 | 57,162 | 2,443,676 | 1,948,883 | 1.9 M to 1.9 M (+3.02 %) |
Nov 01 2013 | KVA, KVB | K-V Pharmaceutical ... | Vergis Janet S. | Director | Option Exercise | A | 0.00 | 3,751 | 0 | 3,751 | |
Nov 01 2013 | KVA, KVB | K-V Pharmaceutical ... | Vergis Janet S. | Director | Option Exercise | A | 32.00 | 5,000 | 160,000 | 5,000 | |
Nov 01 2013 | KVA, KVB | K-V Pharmaceutical ... | Vergis Janet S. | Director | Option Exercise | A | 28.80 | 15,000 | 432,000 | 15,000 | |
Oct 25 2013 | KVA, KVB | K-V Pharmaceutical ... | MAHADY JOSEPH M | Director | Option Exercise | A | 0.00 | 7,142 | 0 | 7,142 | |
Oct 25 2013 | KVA, KVB | K-V Pharmaceutical ... | MAHADY JOSEPH M | Director | Option Exercise | A | 32.00 | 10,000 | 320,000 | 10,000 | |
Oct 25 2013 | KVA, KVB | K-V Pharmaceutical ... | MAHADY JOSEPH M | Director | Option Exercise | A | 28.80 | 30,000 | 864,000 | 30,000 | |
Oct 23 2013 | KVA, KVB | K-V Pharmaceutical ... | Goldfarb James M. | Director | Option Exercise | A | 0.00 | 3,751 | 0 | 3,751 | |
Oct 23 2013 | KVA, KVB | K-V Pharmaceutical ... | Goldfarb James M. | Director | Option Exercise | A | 32.00 | 5,000 | 160,000 | 5,000 | |
Oct 23 2013 | KVA, KVB | K-V Pharmaceutical ... | Goldfarb James M. | Director | Option Exercise | A | 28.80 | 15,000 | 432,000 | 15,000 | |
Oct 23 2013 | KVA, KVB | K-V Pharmaceutical ... | Norden Gregory | Director | Option Exercise | A | 0.00 | 3,751 | 0 | 3,751 | |
Oct 23 2013 | KVA, KVB | K-V Pharmaceutical ... | Norden Gregory | Director | Option Exercise | A | 32.00 | 5,000 | 160,000 | 5,000 | |
Oct 23 2013 | KVA, KVB | K-V Pharmaceutical ... | Norden Gregory | Director | Option Exercise | A | 28.80 | 15,000 | 432,000 | 15,000 |